Application 209970
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MESALAMINE | MESALAMINE | CAPSULE, EXTENDED RELEASE;ORAL | 375MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209970-001 | MESALAMINE | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2022-05-06 | 5c6f7cd8ea54… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2022-05-06 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2022-05-06 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2022-05-06 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2022-05-06 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A209970-001 | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE / ORAL | 2022-05-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209970-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209970-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A209970-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A209970-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A209970-001 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mesalamine | MESALAMINE | Ingenus Pharmaceuticals, LLC | 58503afe-b8d4-4710-a194-e3acd64ecf1f | 2026-11-05 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| MESALAMINE | MESALAMINE | KLM Laboratories Private Limited | 54cfed92-5e28-4a4d-a70f-2a60b5b54c12 | 2026-11-03 | Warnings, Adverse reactions | MESALAMINE MESALAMINE |
| Mesalamine | MESALAMINE | Aurobindo Pharma Limited | d6c0fc76-644e-4301-9672-f432061e3d37 | 2026-11-02 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| mesalamine | MESALAMINE | Zydus Pharmaceuticals USA Inc. | 533bfaf5-0add-4b49-a4f2-ddea2b83f65d | 2026-10-27 | Warnings, Adverse reactions | mesalamine MESALAMINE |
| Lialda | MESALAMINE | Takeda Pharmaceuticals America, Inc. | 3098a080-be86-4265-9818-7fc4beab77b7 | 2026-10-26 | Warnings, Adverse reactions | MESALAMINE |
| Mesalamine | MESALAMINE | Takeda Pharmaceuticals America, Inc. | 4e3b6325-a5bf-4c47-931c-142c0e4d7c3a | 2026-10-23 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Pentasa | MESALAMINE | Takeda Pharmaceuticals America, Inc. | e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606 | 2026-10-23 | Warnings, Adverse reactions | MESALAMINE |
| APRISO | MESALAMINE | Salix Pharmaceuticals, Inc. | 7951139c-b271-45a4-b523-34b23800917b | 2026-10-22 | Warnings, Adverse reactions | MESALAMINE |
| Mesalamine | MESALAMINE | Zydus Pharmaceuticals USA Inc. | cd8493f7-91fd-4c2d-b3d7-c1301825586b | 2026-10-22 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Ascend Laboratories, LLC | 43f69db3-81ac-4da4-a61f-fbba6299d9c2 | 2026-10-19 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Canasa | MESALAMINE | Allergan, Inc. | 89d91601-152b-4398-bebe-af1c023e9935 | 2026-10-14 | Warnings, Adverse reactions | MESALAMINE |
| Mesalamine | MESALAMINE | Teva Pharmaceuticals, Inc. | e3b84397-a5a5-40cf-8145-0584103d465f | 2026-09-22 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Teva Pharmaceuticals USA, Inc. | 6fd0a906-e1b5-4238-a79b-a195510ddc84 | 2026-09-21 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | American Health Packaging | c1ed6fcc-7fd4-4b8a-9ddb-e772ea930e9e | 2026-09-17 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| mesalamine | MESALAMINE | Zydus Pharmaceuticals USA Inc. | ad8c7930-92e2-4372-a874-da22b9ae333e | 2026-09-17 | Warnings, Adverse reactions | mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Amneal Pharmaceuticals LLC | 00f77203-3615-47e8-ae25-6e1cf8a2a00a | 2026-09-16 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Rowasa | MESALAMINE | Viatris Specialty LLC | e505ab99-1943-4216-a178-4d5dbe64e3b2 | 2026-08-03 | Warnings, Adverse reactions | MESALAMINE |
| mesalamine | MESALAMINE | Major Pharmaceuticals | 14ac4435-903b-41f5-a3c4-8c73de3e4cef | 2026-07-27 | Warnings, Adverse reactions | mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Sandoz Inc | 47b5d1ee-b439-4ccb-9b01-c0875ccd748a | 2026-06-30 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Nuvaila Limited | 875d573f-99a1-426a-8321-4d511690d503 | 2026-06-03 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.